BTIG Downgrades Tscan Therapeutics Inc (TCRX) to Neutral Nov 4, 2025 06:03AM
TScan reaches FDA agreement on pivotal study design for TSC-101 Nov 3, 2025 06:30AM
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 Nov 3, 2025 06:30AM